Coave Therapeutics to Present at Upcoming Conferences

Paris, France, September 28, 2023 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies for CNS (Central Nervous System) and eye diseases, announces that CEO Rodolphe Clerval will be presenting to investors and peers at the following Investor and Industry conferences: Chardan’s 7th Annual Genetic Medicines Conference – October 2-3 New York City, NY, USAPresenting on October 2 at 11:30 EDT Cell & Gene Meeting on the Mesa – October 10-12 Carlsbad,

Related Keywords

Netherlands ,United States ,Paris ,France General ,France ,Torremolinos ,Andalucísp ,Spain ,Belgium ,New York ,Amsterdam ,Noord Holland ,Brussels ,Bruxelles Capitale ,Clerval ,Franche Comtér ,United Kingdom ,London ,City Of ,G Le Meur , ,International Symposium On Retinal Degeneration ,Unilateral Subretinal Administration ,European Society Of Retina Specialists Congress ,European Society Of Gene ,Coave Therapeutics ,Central Nervous System ,Annual Genetic Medicines Conference ,York City ,Gene Meeting ,Path To Commercialization In Gene ,London Healthcare Conference ,Regulatory Conferences ,European Society ,Retina Specialists ,Retinitis Pigmentosa ,Harbouring Mutations ,Gene Leading ,International Symposium ,Retinal Degeneration ,Cell Therapy ,Annual Congress ,Ligand Conjugate ,Advanced Vectors Ligand Conjugates ,Lipid Nanoparticles ,Genetic Medicine ,Eye Diseases ,Rodolphe Clerval ,Industry Conferences ,Herapeutics ,European Society Of Retina Specialists ,Jefferies London Healthcare Conference ,